“It’s very important that funding for the medical cannabis experiment is now integrated into this process,” said Benjamin-Alexandre Jeanroy, CEO of Augur Associates in Paris, back in 2019 regarding the importance of moving forward and making something happen. "While France has technically approved such an experiment a year ago through legal channels, there needs to be actual implementation to get something off the ground and into the trial stage so that progress can be monitored."
Continuer à lire sur High Times.